Bioventus Inc. Class A Common Stock vs. ResMed Inc.
ResMed Inc. (RMD) comes out ahead, leading on 5 of 9 compared factors.
Size & Scale
| BVS | RMD | |
|---|---|---|
| Market Cap | $881.82 million | $32.02 billion |
| Revenue (TTM) | $581.85 million | $5.65 billion |
| Net Income (TTM) | $61.48 million | $1.52 billion |
RMD leads on 3 of 3 size & scale factors.
Valuation
| BVS | RMD | |
|---|---|---|
| P/E Ratio | 17.29 | 21.29 |
| Price / Book | 3.18 | 4.86 |
| Price / Sales | 1.52 | 5.66 |
BVS leads on 3 of 3 valuation factors.
Profitability
| BVS | RMD | |
|---|---|---|
| Net Margin | 10.57% | 26.94% |
| Return on Equity | 22.16% | 23.13% |
RMD leads on 2 of 2 profitability factors.
Dividend
| BVS | RMD | |
|---|---|---|
| Dividend Yield | — | 1.19% |
| Payout Ratio | — | 25.31 |
BVS and RMD split the dividend factors evenly.
Risk & Sentiment
| BVS | RMD | |
|---|---|---|
| Short Interest | 0.78% | 4.04% |
BVS leads on 1 of 1 risk & sentiment factors.
Dig deeper: BVS overview, BVS financials, RMD overview, RMD financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.